C. Scriver, ThePAH gene, phenylketonuria, and a paradigm shift, Human Mutation, vol.21, issue.9, pp.831-876, 2007.
DOI : 10.1002/ajmg.1320560404

P. Guldberg, F. Rey, J. Zschocke, V. Romano, B. Francois et al., A European Multicenter Study of Phenylalanine Hydroxylase Deficiency: Classification of 105 Mutations and a General System for Genotype-Based Prediction of Metabolic Phenotype, The American Journal of Human Genetics, vol.63, issue.1, pp.71-80, 1998.
DOI : 10.1086/301920

C. Heintz, R. Cotton, and N. Blau, Tetrahydrobiopterin, its Mode of Action on Phenylalanine Hydroxylase, and Importance of Genotypes for Pharmacological Therapy of Phenylketonuria, Human Mutation, vol.29, issue.1, pp.927-963, 2013.
DOI : 10.1002/humu.20637

F. Feillet, F. Van-spronsen, A. Macdonald, F. Trefz, M. Demirkol et al., Challenges and Pitfalls in the Management of Phenylketonuria, PEDIATRICS, vol.126, issue.2, pp.333-374, 2010.
DOI : 10.1542/peds.2009-3584

H. Levy, A. Milanowski, A. Chakrapani, M. Cleary, P. Lee et al., Efficacy of sapropterin dihydrochloride (tetrahydrobiopterin, 6R-BH4) for reduction of phenylalanine concentration in patients with phenylketonuria: a phase III randomised placebo-controlled study, The Lancet, vol.370, issue.9586, pp.504-514, 2007.
DOI : 10.1016/S0140-6736(07)61234-3

S. Gersting, K. Kemter, M. Staudigl, D. Messing, M. Danecka et al., Loss of Function in Phenylketonuria Is Caused by Impaired Molecular Motions and Conformational Instability, The American Journal of Human Genetics, vol.83, issue.1, pp.5-17, 2008.
DOI : 10.1016/j.ajhg.2008.05.013

A. Pey, B. Perez, L. Desviat, M. Martinez, C. Aguado et al., Mechanisms underlying responsiveness to tetrahydrobiopterin in mild phenylketonuria mutations, Human Mutation, vol.269, issue.Suppl 1, pp.388-99, 2004.
DOI : 10.1021/bi034021s

M. Staudigl, S. Gersting, M. Danecka, D. Messing, M. Woidy et al., The interplay between genotype, metabolic state and cofactor treatment governs phenylalanine hydroxylase function and drug response, Human Molecular Genetics, vol.20, issue.13, pp.2628-2669, 2011.
DOI : 10.1093/hmg/ddr165

M. Zurfluh, J. Zschocke, M. Lindner, F. Feillet, C. Chery et al., Molecular genetics of tetrahydrobiopterin-responsive phenylalanine hydroxylase deficiency, Human Mutation, vol.21, issue.1, pp.167-75, 2008.
DOI : 10.1007/s00726-002-0354-0

M. Quirk, S. Dobrowolski, B. Nelson, B. Coffee, and R. Singh, Utility of phenylalanine hydroxylase genotype for tetrahydrobiopterin responsiveness classification in patients with phenylketonuria, Molecular Genetics and Metabolism, vol.107, issue.1-2
DOI : 10.1016/j.ymgme.2012.07.008

F. Trefz, D. Scheible, H. Gotz, and G. Frauendienst-egger, Significance of genotype in tetrahydrobiopterin-responsive phenylketonuria, Journal of Inherited Metabolic Disease, vol.29, issue.1, pp.22-28, 2009.
DOI : 10.1016/j.bbadis.2006.02.001

L. Aldamiz-echevarria, M. Bueno, M. Couce, S. Lage, J. Dalmau et al., 6R-tetrahydrobiopterin treated PKU patients below 4years of age: Physical outcomes, nutrition and genotype, Molecular Genetics and Metabolism, vol.115, issue.1, pp.10-16, 2015.
DOI : 10.1016/j.ymgme.2015.03.007

K. Anjema, M. Van-rijn, F. Hofstede, A. Bosch, C. Hollak et al., Tetrahydrobiopterin responsiveness in phenylketonuria: prediction with the 48-hour loading test and genotype, Orphanet Journal of Rare Diseases, vol.8, issue.1, p.103, 2013.
DOI : 10.1136/gut.26.9.907

M. Couce, M. Boveda, A. Fernandez-marmiesse, A. Miras, B. Perez et al., Molecular epidemiology and BH4-responsiveness in patients with phenylalanine hydroxylase deficiency from Galicia region of Spain, Gene, vol.521, issue.1, pp.100-104, 2013.
DOI : 10.1016/j.gene.2013.03.004

J. Hennermann, S. Roloff, C. Gebauer, B. Vetter, A. Von-arnim-baas et al., Long-term treatment with tetrahydrobiopterin in phenylketonuria: Treatment strategies and prediction of long-term responders, Molecular Genetics and Metabolism, vol.107, issue.3, pp.294-301, 2012.
DOI : 10.1016/j.ymgme.2012.09.021

J. Nielsen, K. Nielsen, and F. Guttler, Tetrahydrobiopterin responsiveness after extended loading test of 12 Danish PKU patients with the Y414C mutation, Journal of Inherited Metabolic Disease, vol.347, issue.1, pp.9-16, 2010.
DOI : 10.1007/s10545-009-9002-0

I. Scala, D. Concolino, D. Casa, R. Nastasi, A. Ungaro et al., Long-term follow-up of patients with phenylketonuria treated with tetrahydrobiopterin: a seven years experience, Orphanet Journal of Rare Diseases, vol.10, issue.1, p.14, 2015.
DOI : 10.1016/j.ymgme.2012.12.006

J. Tao, N. Li, H. Jia, Z. Liu, X. Li et al., Correlation between genotype and the tetrahydrobiopterin-responsive phenotype in Chinese patients with phenylketonuria, Pediatric Research, vol.6, issue.6
DOI : 10.1038/ejhg.2014.114

J. Utz, C. Lorentz, D. Markowitz, K. Rudser, B. Diethelm-okita et al., START, a double blind, placebo-controlled pharmacogenetic test of responsiveness to sapropterin dihydrochloride in phenylketonuria patients, Molecular Genetics and Metabolism, vol.105, issue.2, pp.193-200, 2012.
DOI : 10.1016/j.ymgme.2011.10.014

N. Blau, F. Van-spronsen, and H. Levy, Phenylketonuria, The Lancet, vol.376, issue.9750, pp.1417-1444, 2010.
DOI : 10.1016/S0140-6736(10)60961-0

S. Brautigam, A. Kujat, P. Kirst, J. Seidel, H. Luleyap et al., DHPLC mutation analysis of phenylketonuria, Molecular Genetics and Metabolism, vol.78, issue.3, pp.205-215, 2003.
DOI : 10.1016/S1096-7192(02)00228-7

H. Erlandsen, M. Patch, A. Gamez, M. Straub, and R. Stevens, Structural studies on phenylalanine hydroxylase and implications toward understanding and treating phenylketonuria, Pediatrics, vol.112, issue.6 2, pp.1557-65, 2003.

K. Camp, M. Parisi, P. Acosta, G. Berry, D. Bilder et al., Phenylketonuria Scientific Review Conference: State of the science and future research needs, Molecular Genetics and Metabolism, vol.112, issue.2, pp.87-122, 2014.
DOI : 10.1016/j.ymgme.2014.02.013

G. Ho, A. I. Bhattacharya, K. Dennison, B. Ellaway, C. Thompson et al., The Molecular Bases of Phenylketonuria (PKU) in New South Wales, Australia: Mutation Profile and Correlation with Tetrahydrobiopterin (BH4) Responsiveness, TetrahydrobiopterinBH4) Responsiveness. JIMD Rep, vol.14, pp.55-65, 2014.
DOI : 10.1007/8904_2013_284

E. Sterl, K. Paul, E. Paschke, J. Zschocke, M. Brunner-krainz et al., Prevalence of tetrahydrobiopterine (BH4)-responsive alleles among Austrian patients with PAH deficiency: comprehensive results from molecular analysis in 147 patients, Journal of Inherited Metabolic Disease, vol.29, issue.1, pp.7-13, 2013.
DOI : 10.1002/humu.20637

S. Dobrowolski, C. Heintz, T. Miller, C. Ellingson, C. Ellingson et al., Molecular genetics and impact of residual in vitro phenylalanine hydroxylase activity on tetrahydrobiopterin responsiveness in Turkish PKU population, Molecular Genetics and Metabolism, vol.102, issue.2, pp.116-137, 2011.
DOI : 10.1016/j.ymgme.2010.11.158

C. Heintz, S. Dobrowolski, H. Andersen, M. Demirkol, N. Blau et al., Splicing of phenylalanine hydroxylase (PAH) exon 11 is vulnerable: Molecular pathology of mutations in PAH exon 11, Molecular Genetics and Metabolism, vol.106, issue.4, pp.403-414, 2012.
DOI : 10.1016/j.ymgme.2012.05.013

F. Song, Y. Qu, T. Zhang, Y. Jin, H. Wang et al., Phenylketonuria mutations in Northern China, Molecular Genetics and Metabolism, vol.86, issue.1, pp.107-125, 2005.
DOI : 10.1016/j.ymgme.2005.09.001

I. Jennings, R. Cotton, and B. Kobe, Functional Analysis, Using in Vitro Mutagenesis, of Amino Acids Located in the Phenylalanine Hydroxylase Active Site, Archives of Biochemistry and Biophysics, vol.384, issue.2, pp.238-282, 2000.
DOI : 10.1006/abbi.2000.2111

M. Danecka, M. Woidy, J. Zschocke, F. Feillet, A. Muntau et al., ) genotypes promotes personalised medicine in phenylketonuria, Journal of Medical Genetics, vol.15, issue.(Suppl), pp.175-85, 2015.
DOI : 10.1016/S0168-9525(99)01761-8

A. Daniele, I. Scala, G. Cardillo, C. Pennino, C. Ungaro et al., Functional and structural characterization of novel mutations and genotype-phenotype correlation in 51 phenylalanine hydroxylase deficient families from Southern Italy, FEBS Journal, vol.47, issue.7, pp.2048-59, 2009.
DOI : 10.1107/S0108767390010224

I. Jennings, R. Cotton, and B. Kobe, Structural interpretation of mutations in phenylalanine hydroxylase protein aids in identifying genotype???phenotype correlations in phenylketonuria, European Journal of Human Genetics, vol.8, issue.9, pp.683-96, 2000.
DOI : 10.1038/sj.ejhg.5200518